<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00143507</url>
  </required_header>
  <id_info>
    <org_study_id>CL3-16257-056</org_study_id>
    <nct_id>NCT00143507</nct_id>
  </id_info>
  <brief_title>The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction</brief_title>
  <official_title>Effects of Ivabradine on Cardiovascular Events in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction. A Three-year Randomised Double-blind Placebo-controlled International Multicentre Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut de Recherches Internationales Servier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Servier</source>
  <brief_summary>
    <textblock>
      The aim of this study is to test whether ivabradine is able to reduce cardiovascular events
      when given to patients with coronary artery disease and impaired heart function.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2004</start_date>
  <completion_date type="Actual">February 2008</completion_date>
  <primary_completion_date type="Actual">February 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Composite Endpoint</measure>
    <time_frame>From the date of randomisation to the date of the first occurrence of the first event, up to 3 years.</time_frame>
    <description>First event among cardiovascular death, hospitalisation for acute myocardial infarction (fatal or not), or hospitalisation for new onset or worsening heart failure (fatal or not).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular Death</measure>
    <time_frame>From the date of randomisation to death, up to 3 years.</time_frame>
    <description>Cardiovascular death including sudden death of unknown cause</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalisation for Acute Myocardial Infarction</measure>
    <time_frame>From the date of randomisation to the date of first occurrence of the event, up to 3 years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalisation for New Onset or Worsening Heart Failure</measure>
    <time_frame>From the date of randomisation to the date of first occurrence of the event, up to 3 years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause of Mortality</measure>
    <time_frame>From the date of randomisation to death, up to 3 years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coronary Artery Disease Death</measure>
    <time_frame>From the date of randomisation to death, up to 3 years.</time_frame>
    <description>Death due to heart failure, acute myocardial infarction or cardiac procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalisation for Coronary Revascularisation</measure>
    <time_frame>From the date of randomisation to the date of first occurrence of the event, up to 3 years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalisation for Unstable Angina</measure>
    <time_frame>From the date of randomisation to the date of first occurrence of the event, up to 3 years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalisation for Acute Coronary Syndrome (Unstable Angina or Acute Myocardial Infarction)</measure>
    <time_frame>From the date of randomisation to the date of first occurrence of the first event, up to 3 years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalisation for Acute Coronary Syndrome, or Coronary Revascularisation</measure>
    <time_frame>From the date of randomisation to the date of first occurrence of the first event, up to 3 years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalisation for Acute Coronary Syndrome, New Onset or Worsening Heart Failure or Coronary Revascularisation</measure>
    <time_frame>From the date of randomisation to the date of first occurrence of the first event, up to 3 years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular Death, or Hospitalisation for New Onset or Worsening Heart Failure</measure>
    <time_frame>From the date of randomisation to the date of first occurrence of the first event, up to 3 years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular Death, or Hospitalisation for Acute Myocardial Infarction</measure>
    <time_frame>From the date of randomisation to the date of the first occurrence of the first event, up to 3 years.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10917</enrollment>
  <condition>Coronary Disease</condition>
  <condition>Ventricular Dysfunction, Left</condition>
  <arm_group>
    <arm_group_label>Ivabradine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ivabradine</intervention_name>
    <arm_group_label>Ivabradine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Coronary artery disease

          -  Left ventricular systolic dysfunction

          -  Sinus rhythm: heart rate (HR) &gt;= 60 beats per minute (bpm)

        Exclusion Criteria:

          -  Unstable cardiovascular condition

          -  Severe congestive heart failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kim Fox, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Royal Brompton National Heart and Lung Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Royal Brompton National Heart and Lung Hospital</name>
      <address>
        <city>London</city>
        <zip>SW3 6NP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://clinicaltrials.servier.com/wp-content/uploads/CL3-16257-056_synopsis_report.pdf</url>
    <description>Results summary</description>
  </link>
  <results_reference>
    <citation>Fox K, Ford I, Steg PG, Tendera M, Ferrari R; BEAUTIFUL Investigators. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet. 2008 Sep 6;372(9641):807-16. doi: 10.1016/S0140-6736(08)61170-8. Epub 2008 Aug 29.</citation>
    <PMID>18757088</PMID>
  </results_reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 31, 2005</study_first_submitted>
  <study_first_submitted_qc>August 31, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 2, 2005</study_first_posted>
  <results_first_submitted>May 13, 2015</results_first_submitted>
  <results_first_submitted_qc>June 22, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 25, 2015</results_first_posted>
  <last_update_submitted>March 13, 2018</last_update_submitted>
  <last_update_submitted_qc>March 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2018</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
    <mesh_term>Ventricular Dysfunction, Left</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Researchers can ask for a study protocol, patient-level and/or study-level clinical trial data including clinical study reports (CSRs).
They can ask all interventional clinical studies:
submitted for new medicines and new indications approved after 1 January 2014 in the European Economic Area (EEA) or the United States (US).
Where Servier or an affiliate are the Marketing Authorization Holders (MAH). The date of the first Marketing Authorization of the new medicine (or the new indication) in one of the EEA Member States will be considered within this scope.</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Eligible participants were men and women, with documented history of coronary artery disease, associated with left ventricular systolic dysfunction. Angina and/or heart failure symptoms should have been stable for â‰¥ 3 months, with optimal conventional cardiovascular medication on appropriate stable doses for at least 1 month.</recruitment_details>
      <pre_assignment_details>Following a run-in period of two weeks during which no study treatment was dispensed, the participants were randomised to receive ivabradine or placebo in addition to their usual cardiovascular treatment in double-blind treatment period.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Ivabradine</title>
          <description>Patients received ivabradine at starting dose of 5 mg twice daily, with a target dose, if HR tolerance criteria were met after two weeks (at the D15 visit), of 7.5 mg twice daily.</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Patients received placebo twice daily.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5479"/>
                <participants group_id="P2" count="5438"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4792"/>
                <participants group_id="P2" count="4786"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="687"/>
                <participants group_id="P2" count="652"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="572"/>
                <participants group_id="P2" count="547"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="114"/>
                <participants group_id="P2" count="102"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawn by sponsor's decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Ivabradine</title>
          <description>Patients received ivabradine at starting dose of 5 mg twice daily, with a target dose, if HR tolerance criteria were met after two weeks (at the D15 visit), of 7.5 mg twice daily.</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Patients received placebo twice daily.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="5479"/>
            <count group_id="B2" value="5438"/>
            <count group_id="B3" value="10917"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.3" spread="8.5"/>
                    <measurement group_id="B2" value="65" spread="8.4"/>
                    <measurement group_id="B3" value="65.2" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="939"/>
                    <measurement group_id="B2" value="931"/>
                    <measurement group_id="B3" value="1870"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4540"/>
                    <measurement group_id="B2" value="4507"/>
                    <measurement group_id="B3" value="9047"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Beta-blocker intake</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4749"/>
                    <measurement group_id="B2" value="4738"/>
                    <measurement group_id="B3" value="9487"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="730"/>
                    <measurement group_id="B2" value="700"/>
                    <measurement group_id="B3" value="1430"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Primary Composite Endpoint</title>
        <description>First event among cardiovascular death, hospitalisation for acute myocardial infarction (fatal or not), or hospitalisation for new onset or worsening heart failure (fatal or not).</description>
        <time_frame>From the date of randomisation to the date of the first occurrence of the first event, up to 3 years.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Patients received ivabradine at starting dose of 5 mg twice daily, with a target dose, if HR tolerance criteria were met after two weeks (at the D15 visit), of 7.5 mg twice daily.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients received placebo twice daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Primary Composite Endpoint</title>
          <description>First event among cardiovascular death, hospitalisation for acute myocardial infarction (fatal or not), or hospitalisation for new onset or worsening heart failure (fatal or not).</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5479"/>
                <count group_id="O2" value="5438"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="844"/>
                    <measurement group_id="O2" value="832"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.945</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.00</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.91</ci_lower_limit>
            <ci_upper_limit>1.10</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake as a covariate. P-value: Log-rank test stratified on beta-blocker intake factor.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cardiovascular Death</title>
        <description>Cardiovascular death including sudden death of unknown cause</description>
        <time_frame>From the date of randomisation to death, up to 3 years.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Patients received ivabradine at starting dose of 5 mg twice daily, with a target dose, if HR tolerance criteria were met after two weeks (at the D15 visit), of 7.5 mg twice daily.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients received placebo twice daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiovascular Death</title>
          <description>Cardiovascular death including sudden death of unknown cause</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5479"/>
                <count group_id="O2" value="5438"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="469"/>
                    <measurement group_id="O2" value="435"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.316</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.07</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.94</ci_lower_limit>
            <ci_upper_limit>1.22</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake as a covariate. P-value: Log-rank test stratified on beta-blocker intake factor.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospitalisation for Acute Myocardial Infarction</title>
        <time_frame>From the date of randomisation to the date of first occurrence of the event, up to 3 years.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Patients received ivabradine at starting dose of 5 mg twice daily, with a target dose, if HR tolerance criteria were met after two weeks (at the D15 visit), of 7.5 mg twice daily.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients received placebo twice daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Hospitalisation for Acute Myocardial Infarction</title>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5479"/>
                <count group_id="O2" value="5438"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="199"/>
                    <measurement group_id="O2" value="226"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.159</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.87</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.72</ci_lower_limit>
            <ci_upper_limit>1.06</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake as a covariate. P-value: Log-rank test stratified on beta-blocker intake factor.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospitalisation for New Onset or Worsening Heart Failure</title>
        <time_frame>From the date of randomisation to the date of first occurrence of the event, up to 3 years.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Patients received ivabradine at starting dose of 5 mg twice daily, with a target dose, if HR tolerance criteria were met after two weeks (at the D15 visit), of 7.5 mg twice daily.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients received placebo twice daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Hospitalisation for New Onset or Worsening Heart Failure</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5479"/>
                <count group_id="O2" value="5438"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="426"/>
                    <measurement group_id="O2" value="427"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.850</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.99</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.86</ci_lower_limit>
            <ci_upper_limit>1.13</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake as a covariate. P-value: Log-rank test stratified on beta-blocker intake factor.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>All-cause of Mortality</title>
        <time_frame>From the date of randomisation to death, up to 3 years.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Patients received ivabradine at starting dose of 5 mg twice daily, with a target dose, if HR tolerance criteria were met after two weeks (at the D15 visit), of 7.5 mg twice daily.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients received placebo twice daily.</description>
          </group>
        </group_list>
        <measure>
          <title>All-cause of Mortality</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5479"/>
                <count group_id="O2" value="5438"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="572"/>
                    <measurement group_id="O2" value="547"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.547</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.04</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.92</ci_lower_limit>
            <ci_upper_limit>1.16</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake as a covariate. P-value: Log-rank test stratified on beta-blocker intake factor.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Coronary Artery Disease Death</title>
        <description>Death due to heart failure, acute myocardial infarction or cardiac procedure</description>
        <time_frame>From the date of randomisation to death, up to 3 years.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Patients received ivabradine at starting dose of 5 mg twice daily, with a target dose, if HR tolerance criteria were met after two weeks (at the D15 visit), of 7.5 mg twice daily.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients received placebo twice daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Coronary Artery Disease Death</title>
          <description>Death due to heart failure, acute myocardial infarction or cardiac procedure</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5479"/>
                <count group_id="O2" value="5438"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="136"/>
                    <measurement group_id="O2" value="151"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.331</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.89</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.71</ci_lower_limit>
            <ci_upper_limit>1.12</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake as a covariate. P-value: Log-rank test stratified on beta-blocker intake factor.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospitalisation for Coronary Revascularisation</title>
        <time_frame>From the date of randomisation to the date of first occurrence of the event, up to 3 years.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Patients received ivabradine at starting dose of 5 mg twice daily, with a target dose, if HR tolerance criteria were met after two weeks (at the D15 visit), of 7.5 mg twice daily.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients received placebo twice daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Hospitalisation for Coronary Revascularisation</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5479"/>
                <count group_id="O2" value="5438"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="155"/>
                    <measurement group_id="O2" value="186"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.078</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.83</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.67</ci_lower_limit>
            <ci_upper_limit>1.02</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake as a covariate. P-value: Log-rank test stratified on beta-blocker intake factor.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospitalisation for Unstable Angina</title>
        <time_frame>From the date of randomisation to the date of first occurrence of the event, up to 3 years.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Patients received ivabradine at starting dose of 5 mg twice daily, with a target dose, if HR tolerance criteria were met after two weeks (at the D15 visit), of 7.5 mg twice daily.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients received placebo twice daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Hospitalisation for Unstable Angina</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5479"/>
                <count group_id="O2" value="5438"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="114"/>
                    <measurement group_id="O2" value="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.583</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.08</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.83</ci_lower_limit>
            <ci_upper_limit>1.40</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake as a covariate. P-value: Log-rank test stratified on beta-blocker intake factor.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospitalisation for Acute Coronary Syndrome (Unstable Angina or Acute Myocardial Infarction)</title>
        <time_frame>From the date of randomisation to the date of first occurrence of the first event, up to 3 years.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Patients received ivabradine at starting dose of 5 mg twice daily, with a target dose, if HR tolerance criteria were met after two weeks (at the D15 visit), of 7.5 mg twice daily.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients received placebo twice daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Hospitalisation for Acute Coronary Syndrome (Unstable Angina or Acute Myocardial Infarction)</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5479"/>
                <count group_id="O2" value="5438"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="303"/>
                    <measurement group_id="O2" value="317"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.501</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.95</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.81</ci_lower_limit>
            <ci_upper_limit>1.11</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake as a covariate. P-value: Log-rank test stratified on beta-blocker intake factor.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospitalisation for Acute Coronary Syndrome, or Coronary Revascularisation</title>
        <time_frame>From the date of randomisation to the date of first occurrence of the first event, up to 3 years.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Patients received ivabradine at starting dose of 5 mg twice daily, with a target dose, if HR tolerance criteria were met after two weeks (at the D15 visit), of 7.5 mg twice daily.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients received placebo twice daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Hospitalisation for Acute Coronary Syndrome, or Coronary Revascularisation</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5479"/>
                <count group_id="O2" value="5438"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="364"/>
                    <measurement group_id="O2" value="401"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.141</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.90</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.78</ci_lower_limit>
            <ci_upper_limit>1.04</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake as a covariate. P-value: Log-rank test stratified on beta-blocker intake factor.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospitalisation for Acute Coronary Syndrome, New Onset or Worsening Heart Failure or Coronary Revascularisation</title>
        <time_frame>From the date of randomisation to the date of first occurrence of the first event, up to 3 years.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Patients received ivabradine at starting dose of 5 mg twice daily, with a target dose, if HR tolerance criteria were met after two weeks (at the D15 visit), of 7.5 mg twice daily.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients received placebo twice daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Hospitalisation for Acute Coronary Syndrome, New Onset or Worsening Heart Failure or Coronary Revascularisation</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5479"/>
                <count group_id="O2" value="5438"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="681"/>
                    <measurement group_id="O2" value="704"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.411</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.96</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.86</ci_lower_limit>
            <ci_upper_limit>1.06</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake as a covariate. P-value: Log-rank test stratified on beta-blocker intake factor.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cardiovascular Death, or Hospitalisation for New Onset or Worsening Heart Failure</title>
        <time_frame>From the date of randomisation to the date of first occurrence of the first event, up to 3 years.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Patients received ivabradine at starting dose of 5 mg twice daily, with a target dose, if HR tolerance criteria were met after two weeks (at the D15 visit), of 7.5 mg twice daily.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients received placebo twice daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiovascular Death, or Hospitalisation for New Onset or Worsening Heart Failure</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5479"/>
                <count group_id="O2" value="5438"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="757"/>
                    <measurement group_id="O2" value="723"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.484</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.04</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.94</ci_lower_limit>
            <ci_upper_limit>1.15</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake as a covariate. P-value: Log-rank test stratified on beta-blocker intake factor.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cardiovascular Death, or Hospitalisation for Acute Myocardial Infarction</title>
        <time_frame>From the date of randomisation to the date of the first occurrence of the first event, up to 3 years.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Patients received ivabradine at starting dose of 5 mg twice daily, with a target dose, if HR tolerance criteria were met after two weeks (at the D15 visit), of 7.5 mg twice daily.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients received placebo twice daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiovascular Death, or Hospitalisation for Acute Myocardial Infarction</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5479"/>
                <count group_id="O2" value="5438"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="606"/>
                    <measurement group_id="O2" value="593"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.835</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.01</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.90</ci_lower_limit>
            <ci_upper_limit>1.13</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake as a covariate. P-value: Log-rank test stratified on beta-blocker intake factor.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From randomization to death, up to 3 years</time_frame>
      <desc>The Randomised Set consisted of 10 917 patients (5479 patients in the ivabradine group and 5438 patients in the placebo group). The Safety Set consisted of 10 907 patients: 10 randomised patients were excluded from the Safety Set because they did not take any study drug (2 patients in the ivabradine group and 8 patients in the placebo group).</desc>
      <group_list>
        <group group_id="E1">
          <title>Ivabradine</title>
          <description>Patients received ivabradine at starting dose of 5 mg twice daily, with a target dose, if HR tolerance criteria were met after two weeks (at the D15 visit), of 7.5 mg twice daily.</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Patients received placebo twice daily.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 7.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1625" subjects_at_risk="5477"/>
                <counts group_id="E2" subjects_affected="1770" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="5477"/>
                <counts group_id="E2" events="11" subjects_affected="9" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Aplastic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hypochromic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Idiopathic thrombocytopenic purpura</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Leukaemoid reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Normochromic normocytic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Accelerated idioventricular rhythm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" events="18" subjects_affected="16" subjects_at_risk="5477"/>
                <counts group_id="E2" events="22" subjects_affected="21" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Acute left ventricular failure</sub_title>
                <counts group_id="E1" events="22" subjects_affected="19" subjects_at_risk="5477"/>
                <counts group_id="E2" events="18" subjects_affected="18" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="85" subjects_affected="82" subjects_at_risk="5477"/>
                <counts group_id="E2" events="96" subjects_affected="88" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="38" subjects_affected="37" subjects_at_risk="5477"/>
                <counts group_id="E2" events="73" subjects_affected="66" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" events="182" subjects_affected="153" subjects_at_risk="5477"/>
                <counts group_id="E2" events="223" subjects_affected="197" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Aortic valve disease mixed</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Aortic valve incompetence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Aortic valve stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Arrhythmia supraventricular</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="145" subjects_affected="127" subjects_at_risk="5477"/>
                <counts group_id="E2" events="162" subjects_affected="134" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" events="38" subjects_affected="35" subjects_at_risk="5477"/>
                <counts group_id="E2" events="30" subjects_affected="28" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Atrial tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="5477"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="5477"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="22" subjects_affected="22" subjects_at_risk="5477"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cardiac asthma</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5477"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="517" subjects_affected="405" subjects_at_risk="5477"/>
                <counts group_id="E2" events="584" subjects_affected="438" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cardiac tamponade</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Congestive cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" events="15" subjects_affected="13" subjects_at_risk="5477"/>
                <counts group_id="E2" events="19" subjects_affected="19" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Coronary artery insufficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Coronary artery stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Coronary artery thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Extrasystoles</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Left ventricular failure</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5477"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Myocardial fibrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="71" subjects_affected="67" subjects_at_risk="5477"/>
                <counts group_id="E2" events="83" subjects_affected="81" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Right ventricular failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Sick sinus syndrome</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Silent myocardial infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Sinoatrial block</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Sinus arrest</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Sinus arrhythmia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Tachyarrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Ventricular arrhythmia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Ventricular bigeminy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Ventricular dysfunction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="5477"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="5477"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" events="28" subjects_affected="28" subjects_at_risk="5477"/>
                <counts group_id="E2" events="58" subjects_affected="53" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Adenomatous polyposis coli</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Congenital intestinal malformation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Epidermal naevus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Deafness unilateral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Sudden hearing loss</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Vestibular disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Vestibular neuronitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Basedow's disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hypercorticoidism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Thyrotoxicosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="5477"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Corneal erosion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Diabetic retinopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Endophthalmitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Exophthalmos endocrine</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Eye haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Retinal artery occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Retinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Uveitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Abdominal haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Abdominal hernia obstructive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Abdominal strangulated hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Acute abdomen</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Appendicitis perforated</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Colitis ulcerative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Colonic polyp</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Crohn's disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal haemorrhagic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastric disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastric polyps</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastric ulcer perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastric volvulus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5477"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastritis atrophic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastritis haemorrhagic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastroduodenitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastrointestinal discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastrointestinal disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="5477"/>
                <counts group_id="E2" events="22" subjects_affected="22" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Inguinal hernia gangrenous</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Intestinal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Intestinal infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Irritable bowel syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Mallory-Weiss syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Mesenteric occlusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Oesophageal stenosis acquired</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Oesophageal varices haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Oesophagitis haemorrhagic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Oesophagitis ulcerative</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pancreatitis due to biliary obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Peptic ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Perirectal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Proctocolitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Reflux oesophagitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Short-bowel syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Sigmoiditis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Small intestinal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Umbilical hernia, obstructive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Application site reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="5477"/>
                <counts group_id="E2" events="22" subjects_affected="21" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="37" subjects_affected="37" subjects_at_risk="5477"/>
                <counts group_id="E2" events="26" subjects_affected="26" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Difficulty in walking</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gait abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Generalised oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" events="204" subjects_affected="204" subjects_at_risk="5477"/>
                <counts group_id="E2" events="185" subjects_affected="185" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Biliary cirrhosis primary</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Biliary colic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Biliary fistula</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="5477"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5477"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cholecystitis chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="5477"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Chronic hepatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cytolytic hepatitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hepatic function abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hepatic lesion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hepatic steatosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hepatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hepatitis acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hepatitis alcoholic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Liver disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Anaphylactic reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Anaphylactic shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Aspergilloma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Borrelia infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bronchial infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bronchiectasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="9" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bronchitis acute</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="5477"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bronchitis acute viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bronchitis chronic</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5477"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bronchopneumonia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Campylobacter gastroenteritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Clostridium colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Dental caries</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Diabetic foot infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Diphyllobothriasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Escherichia urinary tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5477"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastroenteritis Norwalk virus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastrointestinal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Groin abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Haematoma infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Helicobacter gastritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Helicobacter infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hepatitis B</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Impetigo</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Implant site infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Labyrinthitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Laryngopharyngitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Lung abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Meningitis pneumococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Obstructive chronic bronchitis with acute exacerbation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Perianal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Peritonsillar abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="75" subjects_affected="71" subjects_at_risk="5477"/>
                <counts group_id="E2" events="72" subjects_affected="64" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pneumonia haemophilus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Postoperative infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pulmonary tuberculosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pyelonephritis chronic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pyonephrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5477"/>
                <counts group_id="E2" events="7" subjects_affected="5" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection viral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Sialoadenitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Superinfection lung</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Systemic mycosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Tooth infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Viral pericarditis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Wound infection staphylococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accidental poisoning</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Arteriovenous graft thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Brain contusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cardiac valve replacement complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cartilage injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage traumatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cerebrospinal fluid leakage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Chest injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Dislocation of joint prosthesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Face injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Graft thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Medical device complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Meniscus lesion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Multiple fractures</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Muscle rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pneumothorax traumatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Polytraumatism</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Postoperative thoracic procedure complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Postoperative wound complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Skull fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Skull fractured base</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Spinal cord injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Spinal cord injury thoracic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Suture related complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Therapeutic agent toxicity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Traumatic brain injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Traumatic fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Traumatic haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Traumatic intracranial haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Vascular procedure complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Angiogram</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Arteriogram coronary</sub_title>
                <counts group_id="E1" events="26" subjects_affected="26" subjects_at_risk="5477"/>
                <counts group_id="E2" events="29" subjects_affected="28" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Biopsy lung</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Blood creatine phosphokinase increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Blood potassium decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cardiovascular evaluation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Catheterisation cardiac</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Colonoscopy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Computerised tomogram abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Computerised tomogram thorax abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Ejection fraction decreased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Heart rate decreased</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Investigation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Liver function test abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Prostatic specific antigen increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Scan myocardial perfusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Transaminases increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Transplant evaluation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" events="27" subjects_affected="26" subjects_at_risk="5477"/>
                <counts group_id="E2" events="26" subjects_affected="25" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus non-insulin-dependent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bone cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gouty arthritis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5477"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Localised osteoarthritis</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="5477"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Lordosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Monoarthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Myofascial pain syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Myositis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Osteitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Osteochondrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Polyarthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Polymyalgia rheumatica</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Polyserositis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Spondylosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Abdominal neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma pancreas</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>B-cell lymphoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Benign breast neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Benign colonic neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bile duct cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Biliary neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bladder cancer recurrent</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bladder papilloma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bone neoplasm malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Brain neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Breast cancer female</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Breast cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bronchial carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cholesteatoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Chronic myelomonocytic leukaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Clear cell carcinoma of the kidney</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5477"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Colon cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Colon cancer stage III</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Colon neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Colorectal cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Colorectal cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Essential thrombocythaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gallbladder cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastric cancer stage IV with metastases</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gastric neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Glioblastoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Glottis carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Laryngeal cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Laryngeal cancer stage II</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Lentigo maligna recurrent</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Lung cancer metastatic</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified stage III</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Lung neoplasm</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="5477"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Lung squamous cell carcinoma stage unspecified</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Malignant fibrous histiocytoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Malignant neoplasm of ampulla of Vater</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Malignant pleural effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Metastases to bone</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Metastases to liver</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Metastatic malignant melanoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Metastatic neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Multiple myeloma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Mycosis fungoides</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Neoplasm prostate</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Oesophageal cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Osteosarcoma metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pelvic neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Penis carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Phaeochromocytoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Polycythaemia vera</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="5477"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Prostate cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Prostate cancer stage III</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Prostatic adenoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Rectal cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Rectosigmoid cancer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Rectosigmoid cancer stage III</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Refractory anaemia with an excess of blasts</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma stage unspecified</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Renal neoplasm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Salivary gland cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Seborrhoeic keratosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Skin carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer stage unspecified</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Thymoma malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Uterine cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Vocal cord neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Brain stem infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Carotid artery atheroma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Carotid artery occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Carotid sinus syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cerebellar infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cerebral atherosclerosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cerebral haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="5477"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="38" subjects_affected="38" subjects_at_risk="5477"/>
                <counts group_id="E2" events="36" subjects_affected="35" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cerebrovascular disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cerebrovascular insufficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cervicobrachial syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Coma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Diabetic hyperosmolar coma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Diabetic neuropathy</sub_title>
                <counts group_id="E1" events="6" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Dizziness postural</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Facial palsy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Facial paresis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hepatic encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hypertensive encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Ischaemic cerebral infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Ischaemic neuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" events="37" subjects_affected="37" subjects_at_risk="5477"/>
                <counts group_id="E2" events="43" subjects_affected="41" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Mononeuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Myelitis transverse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Parkinson's disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Polyneuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Radial nerve palsy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Radiculitis lumbosacral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Spinal cord infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="21" subjects_affected="19" subjects_at_risk="5477"/>
                <counts group_id="E2" events="19" subjects_affected="19" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Syncope vasovagal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Thrombotic stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="5477"/>
                <counts group_id="E2" events="26" subjects_affected="26" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Vertebrobasilar insufficiency</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Completed suicide</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Intentional self-injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Neurosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Panic attack</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pathological gambling</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Azotaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bilateral hydronephrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bladder tamponade</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Calculus bladder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Calculus ureteric</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Diabetic nephropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Nephropathy toxic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Renal artery stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="5477"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Renal insufficiency</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="5477"/>
                <counts group_id="E2" events="15" subjects_affected="14" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Urethral meatus stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Urethral obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Urinary bladder polyp</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5477"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hydrocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Metrorrhagia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Phimosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Postmenopausal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Prostatism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Testicular torsion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Uterine polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Uterine prolapse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Vaginal prolapse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Asphyxia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bronchopneumopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Chronic obstructive airways disease</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Chronic obstructive airways disease exacerbated</sub_title>
                <counts group_id="E1" events="20" subjects_affected="19" subjects_at_risk="5477"/>
                <counts group_id="E2" events="28" subjects_affected="21" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Diaphragm muscle weakness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Diaphragmatic hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Dyspnoea exacerbated</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hydrothorax</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Lung disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Maxillary sinusitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Nasal polyps</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pharyngeal cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pulmonary artery thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pulmonary congestion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="5477"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pulmonary haemosiderosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pulmonary infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pulmonary sarcoidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Vocal cord disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Wegener's granulomatosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Cutaneous vasculitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Dermatitis allergic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Diabetic gangrene</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Lichen planus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pyoderma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pyoderma gangrenosum</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Rash papular</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Stasis dermatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Abdominal hernia repair</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm repair</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Aortic valve replacement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Arrhythmia prophylaxis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Arterial bypass operation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Arterial stent insertion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Arterial therapeutic procedure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cardiac aneurysm repair</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cardiac operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker insertion</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker revision</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cardiac rehabilitation therapy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cardiac resynchronisation therapy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Carotid endarterectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cataract extraction</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Catheter removal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Colectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Coronary angioplasty</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="5477"/>
                <counts group_id="E2" events="19" subjects_affected="19" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Coronary arterial stent insertion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Coronary artery surgery</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="5477"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Coronary revascularisation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus management</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Finger amputation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gingival operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hip arthroplasty</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Implantable defibrillator insertion</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="5477"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Incisional hernia repair</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Inguinal hernia repair</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Knee arthroplasty</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Knee operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Mitral valve repair</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Mitral valve replacement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Nasal polypectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Orchidectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Penile prosthesis insertion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Peripheral artery angioplasty</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Prostatectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Radioactive iodine therapy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Renal revascularisation surgery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Scar excision</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Shoulder operation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Spinal laminectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Thromboendarterectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Thyroidectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Tooth extraction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Transurethral microwave therapy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Umbilical hernia repair</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Varicose vein operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Varicose veins ligation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Vasodilation procedure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Vitrectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Wart excision</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aneurysm ruptured</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Angiopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm rupture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Aortic thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Arterial embolism limb</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Arterial occlusive disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Arterial stenosis limb</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Arterial thrombosis limb</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Arteriopathic disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Atherosclerosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Atherosclerosis obliterans</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Blood pressure inadequately controlled</sub_title>
                <counts group_id="E1" events="17" subjects_affected="16" subjects_at_risk="5477"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="5477"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Diabetic peripheral angiopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Extremity necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Femoral arterial stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Femoral artery occlusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="5477"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hypertensive emergency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Iliac artery stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Iliac artery thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Iliac vein thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Intermittent claudication</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5477"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Leriche syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Lymphocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Lymphoedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Peripheral artery aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Peripheral embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5477"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Peripheral occlusive disease</sub_title>
                <counts group_id="E1" events="17" subjects_affected="17" subjects_at_risk="5477"/>
                <counts group_id="E2" events="30" subjects_affected="28" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis superficial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Varicose ulceration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5477"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Venous thrombosis limb</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5477"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_vocab>MedDRA 7.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2570" subjects_at_risk="5477"/>
                <counts group_id="E2" subjects_affected="2221" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="62" subjects_affected="61" subjects_at_risk="5477"/>
                <counts group_id="E2" events="61" subjects_affected="60" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="108" subjects_affected="100" subjects_at_risk="5477"/>
                <counts group_id="E2" events="110" subjects_affected="98" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="203" subjects_affected="172" subjects_at_risk="5477"/>
                <counts group_id="E2" events="167" subjects_affected="148" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="189" subjects_affected="185" subjects_at_risk="5477"/>
                <counts group_id="E2" events="51" subjects_affected="50" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="198" subjects_affected="176" subjects_at_risk="5477"/>
                <counts group_id="E2" events="210" subjects_affected="188" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" events="102" subjects_affected="99" subjects_at_risk="5477"/>
                <counts group_id="E2" events="100" subjects_affected="95" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Phosphenes</sub_title>
                <counts group_id="E1" events="219" subjects_affected="206" subjects_at_risk="5477"/>
                <counts group_id="E2" events="49" subjects_affected="46" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="50" subjects_affected="47" subjects_at_risk="5477"/>
                <counts group_id="E2" events="67" subjects_affected="59" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="62" subjects_affected="59" subjects_at_risk="5477"/>
                <counts group_id="E2" events="60" subjects_affected="56" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" events="44" subjects_affected="41" subjects_at_risk="5477"/>
                <counts group_id="E2" events="56" subjects_affected="56" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="83" subjects_affected="71" subjects_at_risk="5477"/>
                <counts group_id="E2" events="100" subjects_affected="80" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Bronchitis acute</sub_title>
                <counts group_id="E1" events="53" subjects_affected="49" subjects_at_risk="5477"/>
                <counts group_id="E2" events="64" subjects_affected="61" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="74" subjects_affected="65" subjects_at_risk="5477"/>
                <counts group_id="E2" events="78" subjects_affected="73" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="89" subjects_affected="84" subjects_at_risk="5477"/>
                <counts group_id="E2" events="98" subjects_affected="87" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="58" subjects_affected="56" subjects_at_risk="5477"/>
                <counts group_id="E2" events="57" subjects_affected="52" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood cholesterol increased</sub_title>
                <counts group_id="E1" events="57" subjects_affected="56" subjects_at_risk="5477"/>
                <counts group_id="E2" events="77" subjects_affected="75" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" events="61" subjects_affected="57" subjects_at_risk="5477"/>
                <counts group_id="E2" events="56" subjects_affected="53" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Blood triglycerides increased</sub_title>
                <counts group_id="E1" events="59" subjects_affected="59" subjects_at_risk="5477"/>
                <counts group_id="E2" events="62" subjects_affected="62" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Heart rate decreased</sub_title>
                <counts group_id="E1" events="164" subjects_affected="164" subjects_at_risk="5477"/>
                <counts group_id="E2" events="36" subjects_affected="34" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" events="68" subjects_affected="68" subjects_at_risk="5477"/>
                <counts group_id="E2" events="55" subjects_affected="54" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" events="155" subjects_affected="150" subjects_at_risk="5477"/>
                <counts group_id="E2" events="192" subjects_affected="171" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" events="49" subjects_affected="44" subjects_at_risk="5477"/>
                <counts group_id="E2" events="63" subjects_affected="57" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="66" subjects_affected="60" subjects_at_risk="5477"/>
                <counts group_id="E2" events="66" subjects_affected="64" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="109" subjects_affected="103" subjects_at_risk="5477"/>
                <counts group_id="E2" events="85" subjects_affected="81" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="60" subjects_affected="55" subjects_at_risk="5477"/>
                <counts group_id="E2" events="60" subjects_affected="53" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal insufficiency</sub_title>
                <counts group_id="E1" events="60" subjects_affected="56" subjects_at_risk="5477"/>
                <counts group_id="E2" events="62" subjects_affected="61" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Blood pressure inadequately controlled</sub_title>
                <counts group_id="E1" events="203" subjects_affected="181" subjects_at_risk="5477"/>
                <counts group_id="E2" events="191" subjects_affected="177" subjects_at_risk="5430"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="50" subjects_affected="46" subjects_at_risk="5477"/>
                <counts group_id="E2" events="72" subjects_affected="70" subjects_at_risk="5430"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review publication and/or communication related to the study results and can require changes. In case of a patent application, the sponsor can delay its authorization for publication or communication of the study results until the date of international registration of the patent.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The section Other Adverse Events (Not including serious) has been completed by the sponsor to include only the Non Serious Adverse Events emergent on treatment during the study.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Therapeutic Innovation Pole</name_or_title>
      <organization>Institut de Recherches Internationales Servier (I.R.I.S.)</organization>
      <phone>+33155724366</phone>
      <email>clinicaltrials@servier.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

